0001181431-14-022240.txt : 20140623 0001181431-14-022240.hdr.sgml : 20140623 20140603134335 ACCESSION NUMBER: 0001181431-14-022240 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140529 FILED AS OF DATE: 20140603 DATE AS OF CHANGE: 20140603 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC CENTRAL INDEX KEY: 0001123494 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043306140 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 84 OCTOBER HILL RD CITY: HOLLISTON STATE: MA ZIP: 01746 BUSINESS PHONE: 5088938999 MAIL ADDRESS: STREET 1: 84 OCTOBER HILL ROAD CITY: HOLLISTON STATE: MA ZIP: 01746 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HARTE NEAL J CENTRAL INDEX KEY: 0001281069 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33957 FILM NUMBER: 14886785 4/A 1 rrd410888.xml X0306 4/A 2014-05-29 2014-06-02 0 0001123494 HARVARD BIOSCIENCE INC HBIO 0001281069 HARTE NEAL J UNIT # 1 83 CHURCH STREET WINCHESTER MA 01890 1 0 0 0 Common Stock 2014-05-29 4 M 0 13317 3.82 A 37575 D Common Stock 2014-05-29 4 S 0 12317 4.27 D 25258 D Common Stock 2014-05-30 4 A 0 19400 0 A 44658 D Stock option (right to buy) 3.82 2014-05-29 4 M 0 13317 0 D 2014-06-21 Common stock, par value $0.01 per share 13317 0 D Represents shares sold to cover the exercise price of the option as part of a broker-assisted cashless exercise. Includes a deferred stock award of 19,400 restricted stock units which shall fully vest on May 30, 2015. Includes (a) a deferred stock award of 19,400 restricted stock units which shall fully vest on May 30, 2015; and (b) a deferred stock award of 3,688 restricted stock units which shall fully vest on June 1, 2015; and (c) 21,570 shares of common stock held by the Reporting Person. The options vested in three equal installments on June 21, 2005, 2006 and 2007. This transaction was executed in multiple trades at prices ranging from $4.2647 to $4.2721. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This form is filed to restate the initial Form 4 filing made on June 2, 2014 in order to correct the reported sale price regarding the shares sold to cover the exercise price of the reported option exercise as part of a broker-assisted cashless exercise. This form is signed under power of attorney. Neal J. Harte 2014-06-03